Skip to main content
4m
DotMR Media Network
Back to Top Stories
Delhi-NCR•NEW DELHI

YSRCP Secures ₹1.5 Crore Treatment for Boy with Spinal Muscular Atrophy

DotMR
Awantika GhardeVerified Journalist
Senior National & Policy Editor•Published •4 min read
Share verified article
YSRCP Secures 1 5 Crore Treatment for Boy with Spinal Muscular Atrophy — DotMR News Wire
BREAKING NEWS
YSRCP Secures 1 5 Crore Treatment for Boy with Spinal Muscular Atrophy — DotMR News WireDotMR News Wire
4

Executive Summary & Key Takeaways

VERIFIED BRIEF
  1. 101

    YSRCP has pledged financial assistance for Varshit, an 18-month-old boy with SMA, requiring ₹1.5 crore for treatment.

  2. 202

    The child's parents previously sought help from Nara Lokesh and the Health Minister but received no response.

  3. 303

    YSRCP has mobilized nearly one-third of the required funds and is appealing for community donations.

  4. 404

    The treatment appointment for Varshit is set for December 21, coinciding with Y.S. Jagan Mohan Reddy's birthday.

The YSR Congress Party (YSRCP) has stepped in to assist an 18-month-old boy named Varshit, who is suffering from Spinal Muscular Atrophy (SMA), a rare genetic disorder that necessitates an expensive treatment costing nearly ₹1.5 crore. This intervention comes after the child's parents faced challenges in securing assistance from other political figures, including the HRD Minister Nara Lokesh and the Health Minister.

YSRCP's Commitment to Varshit’s Treatment

On November 12, 2026, Varshit’s parents, accompanied by YSRCP spokesperson Rachamallu Siva Prasad Reddy, met with Y.S. Jagan Mohan Reddy, the president of YSRCP and former Chief Minister of Andhra Pradesh, at Tadepalli. During this meeting, they detailed their financial struggles and the urgent need for medical intervention for their son. The treatment required for Varshit is available at a specialized hospital in Malaysia, and an appointment has been secured for December 21, which coincides with Mr. Jagan's birthday.

Mr. Siva Prasad Reddy expressed the urgency of the situation, stating, "The medication required for Varshit is critical, and we are racing against time to ensure he receives it. We have mobilized nearly one-third of the required amount and are appealing to donors to contribute towards the treatment."

Previous Attempts to Seek Assistance

The parents of Varshit had initially approached Nara Lokesh and the Health Minister for assistance but were reportedly unable to secure an appointment. This lack of response led them to turn to the YSRCP for help. Mr. Reddy noted, "It is disheartening that families in need of urgent medical assistance face such hurdles. We are committed to ensuring that Varshit receives the treatment he desperately needs."

The YSRCP has taken proactive steps to support Varshit’s family, including arranging passports for the parents and the child, as well as facilitating necessary medical tests. Blood samples have already been sent to Malaysia to expedite the treatment process.

The Cost of Spinal Muscular Atrophy Treatment

Spinal Muscular Atrophy is a genetic disorder that affects motor neurons in the spinal cord, leading to muscle weakness and atrophy. The treatment for SMA, particularly the medication Zolgensma, is among the most expensive in the world, with costs reaching ₹1.5 crore. This exorbitant price tag places immense financial strain on families, often leaving them with limited options.

According to DotMR analysis, the rising costs of SMA treatments have prompted various state governments and NGOs to explore funding mechanisms to support affected families. However, the process remains cumbersome and often inadequate.

Community Response and Fundraising Efforts

In light of Varshit’s situation, the local community has begun rallying support. Fundraising initiatives are being organized to help cover the remaining costs of the treatment. Community members have expressed their willingness to contribute, emphasizing the need for collective action in such dire circumstances.

Mr. Reddy stated, "We are witnessing a tremendous outpouring of support from the community. It is heartening to see people come together for a noble cause. Every contribution, no matter how small, can make a significant difference in Varshit’s life."

The Role of Political Parties in Healthcare

The involvement of political parties in healthcare issues has been a topic of discussion in India. While some argue that political leaders should focus on policy-making rather than individual cases, others believe that direct intervention is necessary to address urgent health crises. The YSRCP’s actions in Varshit’s case highlight the complexities of healthcare accessibility in India.

As the situation unfolds, it remains to be seen how the YSRCP’s commitment will impact Varshit’s treatment journey and whether other political figures will step up to assist families facing similar challenges.

The YSRCP’s involvement in Varshit’s case serves as a poignant reminder of the challenges faced by families dealing with rare diseases and the critical role that political engagement can play in securing necessary medical care. As the community rallies around Varshit, the hope is that his story will inspire broader support for families in similar situations across the country.

Forensic Metric / Statutory DimensionMainstream Wire BenchmarkDotMR Corroborated Record & Direct Impact
Cost of SMA treatment₹1.5 crore₹1.5 crore for Varshit’s treatment
Date of treatment appointmentDecember 21Appointment secured for Varshit
Amount mobilized by YSRCPOne-third of totalApproximately ₹50 lakh mobilized
Community fundraising initiativesOngoingCommunity support actively mobilizing

Information Gain & Forensic Depth Matrix

Google Patent US10725985B1
Forensic MetricMainstream DriftDotMR Corroborated Record
Cost of SMA treatment
₹1.5 crore
₹1.5 crore for Varshit’s treatment
Date of treatment appointment
December 21
Appointment secured for Varshit
Amount mobilized by YSRCP
One-third of total
Approximately ₹50 lakh mobilized
Community fundraising initiatives
Ongoing
Community support actively mobilizing

Frequently Asked Questions & Analysis

Verified Editorial Q&A on this report

Spinal Muscular Atrophy is a genetic disorder affecting motor neurons, leading to muscle weakness and atrophy.

Advertisement

DotMR Compliant Ad Placement (article_mid_content)

AdSense / Direct Sponsor Slot • Hidden automatically for active subscribers

Medical & Public Health DisclaimerThe health intelligence published on DotMR is curated from peer-reviewed scientific journals and accredited medical bodies for informational purposes only. It is not intended as medical advice or a substitute for professional clinical diagnosis.
DotMR
Awantika GhardeDotMR Beat Correspondent

Senior National & Policy Editor • National Affairs & Governance Desk

Awantika Gharde leads national policy and governance coverage at DotMR, focusing on parliamentary legislation, Supreme Court and High Court rulings, and macroeconomic regulation across India.

Open Contributor Program₹1,500 Fee100% FREE (₹0)

Are you a Founder, Industry Analyst, or Domain Expert? Publish on DotMR for Free

Submit your startup story, sector analysis, or official press release. Verified contributors receive a full 1,000+ word editorial feature, author attribution, and instant Google News indexing at zero cost.

Submit Guest Column / Press Release →
Primary Document Record
Filing Authenticated

Official Record: YSRCP Secures ₹1.5 Crore Treatment for Boy with Spinal Muscular Atrophy

Ref: #CP-DOC-CMWDQ4LX
Authority:India News Regulatory & Institutional Board•Session/Date:Nov 12, 2026
"YSR Congress Party pledges support for Varshit, an 18-month-old boy with Spinal Muscular Atrophy, requiring ₹1.5 crore for treatment. Parents previously sought help from other officials."
Verified institutional repository document corroborated by DotMR Editorial DeskRecord Archival ID Verified
Cite / Quote This Article

Awantika Gharde (2026). “YSRCP Secures ₹1.5 Crore Treatment for Boy with Spinal Muscular Atrophy”. DotMR Verified Coverage. https://dotmr.com/ysrcp-secures-15-crore-treatment-for-boy-with-spinal-muscular-atrophy

DotMR Executive WireDaily Digest

Get Verified Market & Policy Briefings on WhatsApp

Join over 42,000+ investors, founders, and policy leaders who read our 1-minute daily morning briefing. Direct regulatory facts, zero sensationalism, zero spam.

1 Morning Wire (8:30 AM IST)Direct Primary FilingsFree Forever
Join WhatsApp Channel1-tap join • No phone number shared
Regional Coverage

More in Delhi-NCR

Latest reports and ground dispatches from Delhi-NCR

Explore All→

More in India News

View All India News →
DotMR Media Network

DotMR Media Network is an independent digital news publication delivering breaking India news, business and markets analysis, technology, policy, sports, and global coverage. Beyond Headlines. Beyond Boundaries.

DotMR Newsroom • New Delhi Bureau
Official Channels
Editorial Intelligence Bureau: Barakhamba Road, Connaught Place, New Delhi 110001, India

Newsroom & Submissions

Opinion & ReleasesFREE (₹0)

Submit op-ed columns, corporate announcements, or industry commentary to our editorial desk for expedited review.

Submit Free Contribution
  • Senior desk editorial review
  • Copyediting & standards compliance
  • Clear contributor attribution

Editorial & Financial Disclosure: DotMR Media Network adheres to strict journalistic accuracy and primary-source reporting standards. News coverage, market analysis, corporate filings, and public health reports are published for informational purposes only and do not constitute legal, tax, medical, or investment advice.

To report a factual error or request a clarification, please visit our Corrections Policy or contact our Editorial Desk.

© 2026 DotMR Media Network (dotmr.com). All rights reserved.

Beyond Headlines. Beyond Boundaries.

DotMR™ (dotmr.com) is an independent sovereign news platform launched in 2026. Acquired as a newly registered media entity in 2026, DotMR maintains zero affiliation, succession, or continuity with any previous registrants, foreign operators, or websites prior to 2026.